Tela Bio Valuation
| TELA Stock | USD 2.99 0.15 4.78% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Tela Bio has a current Real Value of $6.59 per share. The regular price of the company is $2.99. Our model measures the value of Tela Bio from inspecting the company fundamentals such as Operating Margin of (0.49) %, return on equity of -3.42, and Shares Outstanding of 39.39 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tela Bio's valuation include:
Price Book 22.9916 | Enterprise Value 142 M | Enterprise Value Ebitda (5.01) | Price Sales 1.7156 | Enterprise Value Revenue 2.0685 |
Undervalued
Today
Please note that Tela Bio's price fluctuation is slightly risky at this time. Calculation of the real value of Tela Bio is based on 3 months time horizon. Increasing Tela Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tela Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tela Stock. However, Tela Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.99 | Real 6.59 | Target 17.6 | Hype 3.17 | Naive 3.11 |
The real value of Tela Stock, also known as its intrinsic value, is the underlying worth of Tela Bio Company, which is reflected in its stock price. It is based on Tela Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Tela Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Tela Bio helps investors to forecast how Tela stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tela Bio more accurately as focusing exclusively on Tela Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tela Bio's intrinsic value based on its ongoing forecasts of Tela Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tela Bio's closest peers. If more than one evaluation category is relevant for Tela Bio we suggest using both methods to arrive at a better estimate.
Tela Bio Cash |
|
Tela Valuation Trend
Comparing Tela Bio's enterprise value against its market capitalization is a good way to estimate the value of Tela Bio uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Tela Bio Total Value Analysis
Tela Bio is at this time expected to have valuation of 142 M with market capitalization of 117.77 M, debt of 41.08 M, and cash on hands of 27.73 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tela Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
142 M | 117.77 M | 41.08 M | 27.73 M |
Tela Bio Investor Information
About 52.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.69. Tela Bio had not issued any dividends in recent years. Based on the analysis of Tela Bio's profitability, liquidity, and operating efficiency, Tela Bio is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Tela Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tela Bio has an asset utilization ratio of 74.89 percent. This suggests that the Company is making $0.75 for each dollar of assets. An increasing asset utilization means that Tela Bio is more efficient with each dollar of assets it utilizes for everyday operations.Tela Bio Ownership Allocation
Tela Bio shows a total of 39.39 Million outstanding shares. Over half of Tela Bio's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tela Bio Profitability Analysis
The company reported the previous year's revenue of 58.45 M. Net Loss for the year was (46.66 M) with profit before overhead, payroll, taxes, and interest of 27.85 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tela Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tela Bio and how it compares across the competition.
About Tela Bio Valuation
The stock valuation mechanism determines Tela Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Tela Bio. We calculate exposure to Tela Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tela Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 40.1 M | 42.1 M | |
| Pretax Profit Margin | (0.80) | (0.84) | |
| Operating Profit Margin | (0.75) | (0.79) | |
| Net Loss | (0.80) | (0.84) | |
| Gross Profit Margin | 0.69 | 0.47 |
Tela Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 22.9 M |
Tela Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Tela Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tela we look at many different elements of the entity such as Tela's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tela Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tela Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tela Bio's worth.Complementary Tools for Tela Stock analysis
When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |